Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Exosome Diagnostic and Therapeutics Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Instrument
      • 1.3.3 Software
      • 1.3.4 Reagents and Kits
    • 1.4 Market Segment by Application
      • 1.4.1 Global Exosome Diagnostic and Therapeutics Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Cancer Institutes
      • 1.4.4 Diagnostic Centres
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Exosome Diagnostic and Therapeutics Production Value 2014-2025
      • 2.1.2 Global Exosome Diagnostic and Therapeutics Production 2014-2025
      • 2.1.3 Global Exosome Diagnostic and Therapeutics Capacity 2014-2025
      • 2.1.4 Global Exosome Diagnostic and Therapeutics Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Exosome Diagnostic and Therapeutics Market Size CAGR of Key Regions
      • 2.2.2 Global Exosome Diagnostic and Therapeutics Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Exosome Diagnostic and Therapeutics Capacity by Manufacturers
      • 3.1.2 Global Exosome Diagnostic and Therapeutics Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Exosome Diagnostic and Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Exosome Diagnostic and Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Exosome Diagnostic and Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Exosome Diagnostic and Therapeutics Price by Manufacturers
    • 3.4 Key Manufacturers Exosome Diagnostic and Therapeutics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Exosome Diagnostic and Therapeutics Market
    • 3.6 Key Manufacturers Exosome Diagnostic and Therapeutics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Instrument Production and Production Value (2014-2019)
      • 4.1.2 Software Production and Production Value (2014-2019)
      • 4.1.3 Reagents and Kits Production and Production Value (2014-2019)
    • 4.2 Global Exosome Diagnostic and Therapeutics Production Market Share by Type
    • 4.3 Global Exosome Diagnostic and Therapeutics Production Value Market Share by Type
    • 4.4 Exosome Diagnostic and Therapeutics Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Exosome Diagnostic and Therapeutics Consumption by Application

    6 Production by Regions

    • 6.1 Global Exosome Diagnostic and Therapeutics Production (History Data) by Regions 2014-2019
    • 6.2 Global Exosome Diagnostic and Therapeutics Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Exosome Diagnostic and Therapeutics Production Growth Rate 2014-2019
      • 6.3.2 United States Exosome Diagnostic and Therapeutics Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Exosome Diagnostic and Therapeutics Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Exosome Diagnostic and Therapeutics Production Growth Rate 2014-2019
      • 6.4.2 European Union Exosome Diagnostic and Therapeutics Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Exosome Diagnostic and Therapeutics Import & Export
    • 6.5 China
      • 6.5.1 China Exosome Diagnostic and Therapeutics Production Growth Rate 2014-2019
      • 6.5.2 China Exosome Diagnostic and Therapeutics Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Exosome Diagnostic and Therapeutics Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Exosome Diagnostic and Therapeutics Consumption by Regions

    • 7.1 Global Exosome Diagnostic and Therapeutics Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Exosome Diagnostic and Therapeutics Consumption by Type
      • 7.2.2 United States Exosome Diagnostic and Therapeutics Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Exosome Diagnostic and Therapeutics Consumption by Type
      • 7.3.2 European Union Exosome Diagnostic and Therapeutics Consumption by Application
    • 7.4 China
      • 7.4.1 China Exosome Diagnostic and Therapeutics Consumption by Type
      • 7.4.2 China Exosome Diagnostic and Therapeutics Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Exosome Diagnostic and Therapeutics Consumption by Type
      • 7.5.2 Rest of World Exosome Diagnostic and Therapeutics Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Thermo Fisher
      • 8.1.1 Thermo Fisher Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.1.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.1.5 Thermo Fisher Recent Development
    • 8.2 NanoSomix
      • 8.2.1 NanoSomix Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.2.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.2.5 NanoSomix Recent Development
    • 8.3 NX PHARMAGEN
      • 8.3.1 NX PHARMAGEN Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.3.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.3.5 NX PHARMAGEN Recent Development
    • 8.4 Malvern
      • 8.4.1 Malvern Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.4.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.4.5 Malvern Recent Development
    • 8.5 Capricor
      • 8.5.1 Capricor Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.5.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.5.5 Capricor Recent Development
    • 8.6 Exosome
      • 8.6.1 Exosome Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.6.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.6.5 Exosome Recent Development
    • 8.7 Exiqon
      • 8.7.1 Exiqon Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.7.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.7.5 Exiqon Recent Development
    • 8.8 System Biosciences
      • 8.8.1 System Biosciences Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.8.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.8.5 System Biosciences Recent Development
    • 8.9 Aegle
      • 8.9.1 Aegle Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.9.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.9.5 Aegle Recent Development
    • 8.10 AMS
      • 8.10.1 AMS Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Exosome Diagnostic and Therapeutics
      • 8.10.4 Exosome Diagnostic and Therapeutics Product Introduction
      • 8.10.5 AMS Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Exosome Diagnostic and Therapeutics Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Exosome Diagnostic and Therapeutics Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Exosome Diagnostic and Therapeutics Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Exosome Diagnostic and Therapeutics Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Exosome Diagnostic and Therapeutics Production Forecast by Type
      • 9.7.2 Global Exosome Diagnostic and Therapeutics Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Exosome Diagnostic and Therapeutics Sales Channels
      • 10.2.2 Exosome Diagnostic and Therapeutics Distributors
    • 10.3 Exosome Diagnostic and Therapeutics Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine, and cultured medium of cell cultures. A sub-type of exosomes, defined as matrix-bound nanovesicles (MBVs), was reported to be present in extracellular matrix (ECM) bioscaffolds (non-fluid). The reported diameter of exosomes is between 30 and 100 nm, which is larger than low-density lipoproteins (LDL) but much smaller than, for example, red blood cells. Exosomes are either released from the cell when multivesicular bodies fuse with the plasma membrane or released directly from the plasma membrane.
      The exosome diagnostic and therapeutics market in North America is estimated to reach a high market valuation by end of 2027 and is projected to grow at a significant rate throughout the period of assessment.
      In 2019, the market size of Exosome Diagnostic and Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Exosome Diagnostic and Therapeutics.

      This report studies the global market size of Exosome Diagnostic and Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Exosome Diagnostic and Therapeutics production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Thermo Fisher
      NanoSomix
      NX PHARMAGEN
      Malvern
      Capricor
      Exosome
      Exiqon
      System Biosciences
      Aegle
      AMS

      Market Segment by Product Type
      Instrument
      Software
      Reagents and Kits

      Market Segment by Application
      Hospitals
      Cancer Institutes
      Diagnostic Centres
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Exosome Diagnostic and Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Exosome Diagnostic and Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Exosome Diagnostic and Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now